Clinical trial
Resting Energy Expenditure in Palliative Cancer Patients (REPAT) - an Explorative Study in Patients With Incurable Cancer
NCT06206785 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resting Energy Expenditure in Palliative Cancer Patients (REPAT) - an Explorative Study in Patients With Incurable Cancer
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 5, 2023
- Completion date
- September 30, 2026
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cachexia, cancer